Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

4(67%)

Results Posted

50%(1 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_2

33%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

Phase 2Efficacy & side effects

2(33.3%)

N/ANon-phased studies

2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(2)

Detailed Status

Recruiting4

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 12 (33.3%)

Phase 22 (33.3%)

N/A2 (33.3%)

Trials by Status

recruiting467%

completed233%

Recent Activity

4 active trials

Showing 5 of 6

recruitingphase_1

Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical Trial

NCT07747324

recruitingnot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT07747324Phase 1

Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical Trial

Recruiting

NCT07317219Not Applicable

Ayahuasca, Esketamine and Body Image Perception

Recruiting

NCT07317232Not Applicable

Ayahuasca, Esketamine and Premenstrual Symptoms

Recruiting

NCT07317206Phase 2

Ayahuasca, Esketamine and PTSD

Recruiting

NCT07212946Phase 2

Ayahuasca and Esketamine for Major Depression

Completed

NCT02914769Phase 1

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6